Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L13 pseudogene 14 (RPL13P14) is a processed pseudogene that resembles the gene encoding ribosomal protein L13 but does not produce a functional protein. Pseudogenes are typically the result of gene duplication or retrotransposition and accumulate mutations that prevent them from being expressed. RPL13P14 is not considered a molecular target, has no documented biological function or disease association, and is not implicated in any drug interactions or therapeutic mechanisms. RPL13P14 is distinct from ribosomal protein L13 (RPL13), which is a functional constituent of the 60S ribosomal subunit involved in protein synthesis, but the pseudogene form does not perform this role. The existence of RPL13P14 is primarily noted as a genomic artifact rather than a functional biomedical entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L13 pseudogene 14 (RPL13P14).